Pulmonary arterial hypertension and heart transplantation: Hemodynamic evolution and survival;Hipertension arterial pulmonar y trasplante cardiaco: Evolucion hemodinamica y supervivencia

Revista Espanola de Cardiologia

Volumn 49, Issue 11, 1996, Pages 804-809

  Delgado Jiménez, Juan Francisco ^a   Gómez Sánchez, Miguel Ángel ^a   Calle Pérez, Germán ^a   Carnero Varo, Andrés ^a   Hernández Afonso, Julio ^a   Tascón Pérez, Juan ^a   Llovet Verdugo, Alfredo ^a   Molina Ruiz, Luis ^a   Rodriguez Hernández, Enrique ^a   Sáenz De La Calzada, Carlos ^a   Rufilanchas Sánchez, Juan José ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

cardiac transplantation; graft failure; heart failure; pulmonary hypertension

Indexed keywords

DOBUTAMINE; INOTROPIC AGENT; NITROPRUSSIDE SODIUM; PROSTACYCLIN; VASODILATOR AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT FAILURE; HEART FAILURE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PULMONARY HYPERTENSION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SURVIVAL RATE;

ADULT; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; SURVIVAL RATE;

EID: 0030280307     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Costard-Jäckle A, Fowler MB. Influence of preoperative pulmonary anery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 1992; 19: 48-54.
2. Levine AB, Levine TB. Patient evaluation for cardiac transplantation. Prog Cardiovasc Dis 1991; 33: 219-228.
3. Murali S, Kormos RL, Uretsky BF, Schechter D, Reddy PS, Hardesty RL et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J 1993; 126: 896-904.
4. Guyton AC, Lindsey AW, Gilluly JJ. The limits of right ventricular compensation following acute increase in pulmonary circulatory resistance. Circ Res 1954; 2: 326-332.
5. Kawaguchi A, Gandjbakhch I, Pavie A. Cardiac transplant recipients with preoperative pulmonary hypertension: evolution of pulmonary hemodinamics and surgical options. Circulation 1989; 80 (Supl 3): 90-96.
6. Bourge RC, Naftel DC, Costanzo-Nordin MR, Kirklin JK, Young JB, Kubo SH et al, for the Transplant Cardiologists Research Database Group. Pretransplantation risk factors for death after heart transplantation: a multi-institutional study. J Heart Lung Transplant 1993; 12: 549-562.
7. Costanzo MR, Liao Y, Grusk BB, O'Sullivan EJ, Cooper RS, Johnson MR et al. Oversizing of donor hearts: beneficial or detrimental? J Heart Lung Transplant 1991; 10: 717-730.
8. Costanzo MR, Augustine S, Bourge R, Bristow M, O'Connell J B, Driscoll D et al. Selection and treatment of candidates for heart transplantation. AHA Medical/Scientific Statement. Circulation 1995; 92: 3.593-3.612.
9. Naeije R, Lipski A, Abramowicz M, Lejeune P, Mélot C, Antoine M et al. Nature of pulmonary hypertension in congestive heart failure. Am J Respir Crit Care Med 1994; 149: 881-887.
10. Bathia SJS, Kirshenbaum JM, Shemin RJ, Cohn LH, Collins JJ, Di Sesa VJ et al. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. Circulation 1987; 76: 819-826.
11. Yeoh TK, Groark SP, Wilson JR, Merrill WH, Pierson RJ. Preoperative indicators of persistent pulmonary hypertension one year after heart transplantation. Heart Lung Transplant 1995; 14 (Supl): 73 [resumen 152].